PpProf. Peptide
← Back to Supplement Library

Magnesium

Gut Health & Immunity

Last reviewed: May 28, 2026

Also Known As: Mg, Mg²⁺; supplemental forms — magnesium glycinate / bisglycinate (general default), magnesium citrate (general + mild laxative), magnesium oxide (cheap laxative, poor general absorption), magnesium L-threonate (marketed for cognition, Magtein brand), magnesium malate, magnesium sulfate (Epsom salt + IV clinical), magnesium taurate, magnesium lactate, magnesium orotate

Supplement Class: Essential mineral / cofactor for 300+ enzymatic reactions / Mg-ATP active energy currency / GABA-A receptor potentiator / NMDA receptor antagonist / natural calcium channel modulator / insulin signaling cofactor / vitamin D activation cofactor

Evidence Tier: Sub-tier breakdown. Strong: deficiency correction; constipation (citrate/oxide via osmotic mechanism); migraine prophylaxis (AAN/AHS Level B at 400–600 mg/day per Pringsheim 2012); eclampsia / pre-eclampsia (IV magnesium sulfate, obstetric context). Moderate: blood pressure reduction (~2 mmHg systolic per Zhang 2016 meta of 34 RCTs); glycemic control / insulin sensitivity (in deficient or diabetic users); pregnancy leg cramps. Emerging/Modest — popular reputation exceeds RCT base: sleep quality (Abbasi 2012 small trial in 46 elderly; limited RCT replication). Negative: idiopathic muscle cramps in adults (Garrison 2020 Cochrane systematic review of 11 RCTs found NO significant effect). Emerging / thin human data: magnesium L-threonate for cognition (Liu 2016 small trial; premium-priced form).

What is magnesium?

Magnesium is an essential mineral and the fourth most abundant cation in the human body, serving as cofactor for over 300 enzymatic reactions including ATP production (Mg-ATP is the active energy currency), DNA synthesis, protein synthesis, muscle contraction, nerve transmission, and blood glucose regulation. Approximately 50–60% of total body magnesium is stored in bone; the rest is intracellular (predominantly muscle) with a small tightly-regulated extracellular fraction. Magnesium deficiency is remarkably common — surveys suggest 45–68% of US adults fall short of the RDA from dietary intake alone — and chronic insufficient intake is associated with increased risk of hypertension, type 2 diabetes, cardiovascular disease, migraine, and impaired immune function. The evidence base for magnesium supplementation requires honest sub-tier breakdown — the same parent-pattern approach used in the vitamin C and vitamin D3 profiles. Strong evidence covers deficiency correction (foundational essential mineral), constipation management via osmotic mechanism (citrate and oxide forms), migraine prophylaxis (AAN/AHS Level B recommendation at 400–600 mg/day per Pringsheim 2012), and IV magnesium sulfate for eclampsia/pre-eclampsia (obstetric specialty context). Moderate evidence covers blood pressure reduction (Zhang 2016 meta of 34 RCTs: ~2 mmHg systolic reduction), glycemic control and insulin sensitivity (particularly in users with diabetes or deficiency), and pregnancy leg cramps. Emerging/Modest evidence with popular reputation exceeding RCT base covers sleep quality (Abbasi 2012 small trial in 46 elderly insomniacs is the most-cited; subsequent RCT replication is limited; effect may be most pronounced in baseline-deficient users), magnesium L-threonate for cognition (Liu 2016 small trial; premium-priced form with thin human evidence). Negative evidence (popular claim debunked) covers idiopathic muscle cramps in adults — Garrison 2020 Cochrane systematic review of 11 RCTs found magnesium did NOT significantly reduce cramp frequency, intensity, or duration in adults with idiopathic muscle cramps. This is the definitive evidence-based refutation of the popular "magnesium for cramps" claim in general adult populations (pregnancy leg cramps and exercise-deficiency contexts differ). The central practical decision in this category is form selection — different magnesium forms have substantially different bioavailability, gut effects, and clinical applications. Glycinate (bisglycinate) is gentle on GI and the default for general supplementation, sleep, and anxiety; citrate is well-absorbed with mild osmotic laxative effect; oxide has poor bioavailability (~4% elemental Mg absorbed) but strong osmotic effect for constipation specifically; L-threonate is marketed for cognition based on Liu 2010 rodent brain-magnesium data with thin human evidence and premium pricing; malate combines with malic acid for fatigue contexts. Standard supplemental dose: 200–400 mg elemental magnesium daily. Supplemental tolerable upper intake level: 350 mg/day (set by laxative threshold, not toxicity — does NOT cap dietary intake). Migraine prophylaxis protocol at 400–600 mg/day intentionally exceeds the UL for that specific therapeutic indication, under neurology supervision.

Reported benefits (per evidence tier):

  • Deficiency correction (foundational essential mineral; 45–68% of US adults below RDA)
  • Constipation relief via osmotic mechanism (citrate, oxide)
  • Migraine prophylaxis (Pringsheim 2012 AAN/AHS Level B at 400–600 mg/day)
  • Eclampsia / pre-eclampsia prevention (IV magnesium sulfate, obstetric)
  • Modest blood pressure reduction (Zhang 2016 meta — ~2 mmHg systolic)
  • Insulin sensitivity and glycemic control support in diabetic/deficient users
  • Pregnancy leg cramp reduction
  • Modest sleep quality improvement in deficient users (Abbasi 2012)
  • Vitamin D activation cofactor (common cause of vitamin D non-response)

Common dose: 200–400 mg elemental magnesium daily for general use. RDA 320 mg women / 420 mg men (total intake including diet). Supplemental UL 350 mg/day from supplements (laxative threshold). Migraine prophylaxis: 400–600 mg/day (above UL, neurology context). Form: glycinate (default), citrate (with mild laxative), oxide (constipation only), threonate (cognition, thin evidence + premium price).

Watch for: Diarrhea/loose stools at high doses (dose- and form-dependent — UL set by this threshold); kidney disease (impaired clearance — coordinate with nephrology); antibiotic interactions (quinolones, tetracyclines — separate by 2+ hours); bisphosphonates (separate by 2+ hours); PPI long-term use causes hypomagnesemia; popular cramp reputation NOT supported by Cochrane evidence; popular sleep reputation exceeds RCT base; magnesium L-threonate cognition evidence is thin and form is premium-priced.

Shop Magnesium on Amazon →

How does magnesium work?

Magnesium is an essential mineral and the fourth most abundant cation in the body. It serves as a cofactor for over 300 enzymatic reactions including ATP production, DNA synthesis, protein synthesis, muscle contraction, nerve transmission, and blood glucose regulation. Approximately 50–60% of total body magnesium is stored in bone; the rest is intracellular (predominantly muscle) with a small extracellular fraction.

  1. ATP production and energy currency. ATP must be bound to magnesium to function as cellular energy currency — Mg-ATP is the active form. This makes magnesium foundational for every energy-requiring process in the body. Deficiency impairs ATP function broadly.
  2. Cofactor for 300+ enzymatic reactions. Magnesium is required for enzymes in glycolysis, the citric acid cycle, fatty acid oxidation, amino acid synthesis, nucleic acid synthesis, and protein synthesis. Foundational metabolic role.
  3. GABA receptor potentiation. Magnesium activates GABA-A receptors (the inhibitory neurotransmitter receptor) and antagonizes NMDA receptors (excitatory) — producing calming, anti-anxiety, and sleep-promoting effects. Mechanism for the sleep/anxiety applications.
  4. Calcium channel regulation. Magnesium acts as a natural calcium channel blocker — regulating calcium entry into cardiac, vascular smooth muscle, and other cells. Mechanism for the modest blood pressure reduction and antiarrhythmic effects.
  5. Insulin signaling cofactor. Magnesium is required for insulin receptor tyrosine kinase activity — proper insulin signal transduction depends on adequate intracellular magnesium. Deficiency contributes to insulin resistance.
  6. Osmotic gut effect (form-dependent). Magnesium ions in the intestine draw water into the lumen via osmotic action — particularly strong with poorly-absorbed forms (oxide) and well-absorbed-but-osmotic forms (citrate). Mechanism for the constipation indication and the dose-limiting diarrhea side effect.
  7. NMDA receptor modulation in CNS. Beyond GABA potentiation, magnesium blocks NMDA glutamate receptors at physiological levels — preventing excessive excitatory signaling. Relevant for migraine prevention, anxiety, and possibly cognitive applications.
  8. Bone mineralization (storage role). 50–60% of body magnesium is in bone alongside calcium. Magnesium contributes to bone matrix formation; deficiency affects bone density.
  9. Magnesium L-threonate brain penetration (specific form). Threonate form was developed specifically to cross the blood-brain barrier more effectively than other forms. Liu 2010 documented brain magnesium increases and learning/memory effects in rodents; Liu 2016 small human trial showed cognitive improvement; broader human evidence is thin.
  10. Cardiovascular and arrhythmia effects. Magnesium supports normal cardiac electrophysiology. IV magnesium sulfate is used in specific clinical contexts (torsades de pointes, refractory atrial fibrillation, eclampsia) — these are emergency medicine applications, not general supplementation.

What does magnesium actually do?

Magnesium has a multi-tier evidence base requiring honest sub-tier breakdown — the same parent-pattern approach used in vitamin C and vitamin D3 profiles. Several applications have Strong evidence, several Moderate, and several have popular reputation that exceeds the actual RCT support.

  1. Deficiency correction (Strong, foundational). Essential mineral; 45–68% of US adults below RDA per surveys. Supplementation reliably corrects deficiency and prevents downstream consequences.
  2. Constipation — osmotic forms (Strong). Magnesium citrate and oxide reliably produce laxative effect via osmotic mechanism. Well-established for both acute and chronic constipation management.
  3. Migraine prophylaxis (Strong). Pringsheim 2012 AAN/AHS Level B recommendation at 400–600 mg/day. One of the better-evidenced complementary interventions for episodic migraine prevention.
  4. Eclampsia and pre-eclampsia (Strong, clinical context). IV magnesium sulfate is standard of care for eclampsia prevention and seizure prophylaxis in pre-eclampsia. Obstetric specialty context.
  5. Blood pressure reduction (Moderate). Zhang 2016 meta of 34 RCTs: ~2 mmHg systolic, ~1.78 mmHg diastolic reduction. Larger in hypertensive populations.
  6. Glycemic control and insulin sensitivity (Moderate). Documented improvements in fasting glucose, HbA1c, and insulin sensitivity in users with type 2 diabetes or insulin resistance, particularly in those with baseline deficiency.
  7. Pregnancy leg cramps (Moderate). Modest reduction in leg cramp frequency in pregnant women. Specific pregnancy context where the evidence supports use.
  8. Sleep quality (Emerging/Modest — popular reputation exceeds RCT base). Abbasi 2012 small trial in elderly insomniacs is the most-cited. Limited subsequent RCT replication. Effect more pronounced in deficient users. Honest framing: thinner evidence than the marketing suggests.
  9. General/idiopathic muscle cramps in adults (Negative — Cochrane null). Garrison 2020 Cochrane systematic review of 11 RCTs found NO statistically significant or clinically meaningful effect on cramp frequency, intensity, or duration in adults with idiopathic muscle cramps. This is the definitive evidence-based debunking of the popular cramps claim.
  10. Magnesium L-threonate for cognition (Emerging/thin human data). Liu 2010 rodent data; Liu 2016 small (n=44) human trial with modest cognitive improvement in older adults with cognitive impairment. Premium-priced form; broader human evidence is limited.
  11. Anxiety and depression (Modest). Some trials suggest magnesium supplementation modestly improves anxiety and depression scores, particularly in deficient users. Evidence base thinner than for established treatments.
  12. Cardiac arrhythmia adjunct (Strong in specific clinical contexts). IV magnesium for torsades de pointes and select atrial fibrillation contexts. Specialty clinical context.
  13. Asthma exacerbation adjunct (Moderate). IV magnesium sulfate has documented bronchodilator effect in severe asthma exacerbations. Emergency medicine context.
  14. PMS symptom reduction (Modest). Some evidence for magnesium reducing PMS symptoms (mood, bloating, cramping).
  15. Bone density (Modest). Magnesium contributes to bone matrix; deficiency impairs bone density. Supplementation in adequate-intake users has smaller effect than calcium/vitamin D combination.
  16. Exercise recovery in deficient athletes (Modest). Benefit specific to users with documented deficiency; not a generic ergogenic.

How is magnesium dosed?

Magnesium dosing depends on form (different bioavailability and effects), indication (general supplementation vs specific clinical applications), and tolerance (laxative dose-limit). The forms-compared decision is the central practical choice in this category.

  1. General supplementation. 200–400 mg elemental magnesium daily. RDA: 320 mg women / 420 mg men (total intake including diet). Supplemental UL: 350 mg/day (laxative threshold).
  2. Sleep / anxiety. 200–400 mg glycinate form, taken pre-bed. Evidence is modest per Abbasi 2012; manage expectations.
  3. Migraine prophylaxis (Pringsheim 2012 AAN Level B). 400–600 mg/day for 8–12 weeks to assess effect. Above general UL — coordinate with neurology.
  4. Constipation. Magnesium citrate 200–400 mg or magnesium oxide 400 mg, titrate to stool consistency. Acute constipation: higher doses of citrate (500–1000 mg) under guidance.
  5. Blood pressure. 300+ mg/day; effect builds over 4–12 weeks (Zhang 2016 meta).
  6. Glycemic control. 300–400 mg/day; effect emerges over 8–12 weeks, particularly in deficient diabetic users.
  7. Pregnancy leg cramps. 300 mg/day under obstetric supervision.
  8. Magnesium L-threonate cognition (if pursuing). 2 g/day threonate compound (approximately 144 mg elemental magnesium) per Liu 2016 protocol. Thin human evidence; expensive.
  9. IV magnesium sulfate (clinical contexts). Eclampsia/pre-eclampsia prophylaxis, torsades de pointes, severe asthma — emergency medicine/obstetric protocols, not general supplementation.

Timeline: gut-motility effects acute (within hours for citrate/oxide). BP and glycemic effects over 4–12 weeks. Migraine prophylaxis effects 8–12 weeks. Sleep effects (if any) within 2–4 weeks.

UL clarification. The 350 mg/day supplemental tolerable upper intake level applies specifically to magnesium from supplements where the laxative threshold becomes problematic. Dietary magnesium has no documented toxicity ceiling in users with normal kidney function. Migraine and clinical-context protocols at 400+ mg/day intentionally exceed the UL for specific therapeutic purpose.

Elemental magnesium content varies by form. Magnesium oxide is ~60% elemental magnesium by mass; magnesium citrate ~16%; magnesium glycinate ~14%; magnesium L-threonate ~7%. Read labels for elemental magnesium content, not just compound weight. A 200 mg dose of magnesium glycinate compound contains less elemental magnesium than 200 mg of magnesium oxide compound.

How to take magnesium

Magnesium is taken orally as capsules, tablets, powder, or liquid. The practical considerations are form selection (matched to goal), elemental magnesium content (varies dramatically across forms), GI tolerance (split dosing for higher amounts), and timing (pre-bed for sleep applications).

AspectRecommendation
Frequency1–2× daily. Split 300+ mg doses into 2 servings to reduce GI/laxative effect and maintain steadier plasma levels.
Best time of dayFor sleep/anxiety: pre-bed (glycinate). For constipation: morning (citrate or oxide). For general use: with largest meal of the day.
FoodWith food reduces GI distress. Avoid taking with calcium supplements or high-calcium foods (compete for absorption). Avoid with high-phytate foods.
FormGlycinate for general use, sleep, anxiety (gentle GI). Citrate for general use + mild laxative effect. Oxide for cheap laxative only. Threonate for cognition (thin evidence + premium price). Malate for fatigue contexts. Sulfate (Epsom salt) for transdermal/bath use.
Standardization markerElemental magnesium content disclosed (not just compound weight). Form clearly identified. cGMP-certified manufacturing. Third-party tested. Reputable brands: Now Foods, Thorne, Pure Encapsulations, Doctor's Best, Klaire Labs, Jigsaw Health, BulkSupplements.
Cycling / storageNo cycling required — chronic daily use is the trial-validated norm. Store in cool dry conditions; some forms (citrate) are hygroscopic.

Which magnesium form should you choose?

Form selection is the central practical decision in magnesium supplementation. Different forms have substantially different bioavailability, gut effects, and clinical applications. The table below summarizes the practical use cases.

FormBioavailabilityBest use case
Glycinate (bisglycinate)High — chelated, gentle on GIGeneral supplementation, sleep/anxiety, users with sensitive GI. The practical default.
CitrateHigh — well-absorbedGeneral supplementation with mild laxative effect; constipation management; cost-efficient.
OxidePoor (~4% elemental Mg absorbed)Cheap, strong laxative effect. Best for constipation specifically; poor choice for general magnesium status correction.
L-ThreonateModerate, designed for blood-brain barrier penetrationCognitive applications. Liu 2016 small human trial; premium-priced; thin evidence base. Only relevant if specifically targeting cognition.
MalateHighFatigue and fibromyalgia contexts; malic acid adds Krebs-cycle substrate. Modest evidence base for these applications.
Sulfate (Epsom salt)Poor orally; IV form clinicalEpsom salt baths (transdermal claims have weak evidence); IV magnesium sulfate for clinical applications (eclampsia, torsades). Not a general oral supplement.
Lactate, taurate, orotateModerate-highLess common forms. Taurate marketed for cardiovascular; orotate marketed for cellular uptake. Smaller evidence bases than glycinate/citrate.

Practical hierarchy. Glycinate for general use and sleep. Citrate for cost-efficient general use with mild laxative tolerance. Oxide for cheap constipation management only. Threonate only if specifically targeting cognition and accepting thin evidence + premium price. Avoid "magnesium blend" products with multiple forms in proprietary amounts.

What does magnesium stack with?

Magnesium is foundational mineral support that pairs naturally with vitamin D3 (activation cofactor), zinc (often deficient together), calcium (with caveats), and the broader sleep, cardiovascular, and metabolic supplement clusters. The three areas below cover the natural stacking categories.

With peptides

Magnesium is foundational mineral support across peptide protocols rather than a mechanism-specific peptide partner. Sleep-related contexts (GH-secretagogue peptides like CJC-1295 and ipamorelin dosed pre-bed for GH pulse alignment) benefit from adequate magnesium status supporting sleep quality. Healing peptides like BPC-157 for tissue repair work alongside magnesium's metabolic foundational role.

With supplements

  1. Vitamin D3 — magnesium is the cofactor for vitamin D activation enzymes. Adequate magnesium status is required for normal vitamin D response. Common foundational pairing.
  2. Zinc — both often deficient together. Foundational mineral pairing. Take separately or with food to manage competition for absorption sites.
  3. Calcium — vitamin D-mediated calcium absorption requires magnesium cofactor. Caution: take separately by 2+ hours (compete for absorption); high-calcium intake can suppress magnesium absorption.
  4. ZMA (Zinc + Magnesium + B6) — bedtime supplement formulation; combines magnesium with zinc and B6.
  5. Melatonin — sleep stacking; different mechanism (circadian) than magnesium (GABA). Compatible.
  6. Glycine — sleep and recovery; complementary to magnesium's GABA effects.
  7. L-theanine — calming/anxiety support; complementary mechanism.
  8. Electrolyte powders — most contain modest magnesium amounts. Compatible.
  9. Creatine — different mechanism, foundational athletic stacking.

With lifestyle

  1. Dietary magnesium sources. Leafy greens, nuts, seeds (pumpkin seeds especially high), whole grains, legumes, dark chocolate. 320–420 mg/day RDA can be met from diet; many users fall short.
  2. Reduce magnesium losses. Alcohol, caffeine (modest), diuretics, and excessive sweating increase magnesium losses. Match supplementation to losses.
  3. Stress management. Chronic stress depletes magnesium. Supplementation alongside stress reduction is more effective than supplementation alone.
  4. Sleep hygiene. Magnesium for sleep works best as adjunct to sleep hygiene (consistent bedtime, dark room, limited screens). Not a substitute.
  5. Hydration. Adequate water intake supports magnesium function and reduces constipation independent of supplementation.
  6. Cardiovascular and DASH-style diet. Magnesium effects on BP work best alongside potassium, dietary nitrate, and the broader Mediterranean/DASH eating pattern.
  7. Athletes and high sweat losses. Increased requirements during heavy training blocks and heat exposure.

Side effects and interactions

Magnesium is exceptionally safe at standard supplemental doses in users with normal kidney function. The main practical considerations are the dose-dependent laxative effect, kidney disease contexts, and specific drug interactions.

Common (mostly transient)

  1. Diarrhea and loose stools. Dose-dependent. Form-dependent (oxide most, glycinate least). The UL of 350 mg/day from supplements is set by laxative threshold. Reduce dose or switch to glycinate to resolve.
  2. Mild GI discomfort at high doses or with empty stomach.
  3. No documented serious adverse events at standard supplemental doses in healthy adults.

Less common (watch-list)

  1. Kidney disease. Impaired magnesium clearance. Hypermagnesemia risk. Coordinate with nephrology before supplementing in CKD.
  2. Hypermagnesemia. Rare with normal kidneys but serious — muscle weakness, hypotension, respiratory depression, cardiac arrest at extreme levels. Almost exclusively occurs in kidney failure or massive overdose.
  3. Heart block / bradycardia. High-dose magnesium can theoretically worsen conduction abnormalities. Generally not a concern at supplemental doses.
  4. Pregnancy and breastfeeding. Generally safe at standard supplemental doses; coordinate with obstetrician for higher doses.
  5. Myasthenia gravis. May worsen neuromuscular weakness. Avoid supplementation; coordinate with neurology.

Drug and supplement interactions

  1. Antibiotics (quinolones, tetracyclines). Magnesium chelates with these antibiotics, reducing absorption. Separate by 2+ hours.
  2. Bisphosphonates (osteoporosis medications). Magnesium reduces absorption. Separate by 2+ hours.
  3. Diuretics. Loop and thiazide diuretics increase magnesium losses; users on chronic diuretics often need supplementation. Potassium-sparing diuretics may increase magnesium retention.
  4. Proton pump inhibitors (PPIs). Long-term PPI use is associated with hypomagnesemia. Users on chronic PPIs often need supplementation.
  5. Calcium supplements. Compete for absorption. Separate timing by 2+ hours.
  6. Antihypertensive medications — modest additive BP-lowering effect. Monitor.
  7. Diabetes medications — modest additive glucose-lowering effect. Monitor.

What we don't know yet about magnesium

Magnesium biology is well-characterized but several open questions remain — particularly around individual status assessment, the form-specificity of effects beyond bioavailability, and the disconnect between popular reputation and RCT evidence in some applications.

Magnesium status assessment is imperfect. Serum magnesium is poorly correlated with intracellular and total body magnesium — most magnesium is intracellular, and serum is tightly regulated. Red blood cell magnesium and ionized magnesium are slightly better but not widely available. Practical individual-status determination is harder than it sounds.

Form-specific effects beyond bioavailability. Different forms have similar elemental magnesium delivery (corrected for bioavailability), but anecdotal experience suggests they may have qualitatively different effects (glycinate for calm, citrate for laxation, threonate for cognition). Whether these qualitative differences hold up in rigorous head-to-head trials isn't precisely characterized.

Sleep evidence base depth. The popular reputation for magnesium as a sleep aid significantly exceeds the underlying RCT base. Whether the practical sleep benefit users report reflects modest real effect, placebo, deficiency correction in users who didn't know they were deficient, or some combination isn't precisely characterized.

Threonate cognition evidence depth. Liu 2016 small trial is the main human reference. Whether magnesium L-threonate produces measurably better cognitive outcomes than other forms at equivalent elemental magnesium content isn't well-characterized in head-to-head trials. The premium pricing isn't robustly supported.

Transdermal magnesium (Epsom salt, magnesium oil). Marketing claims for transdermal magnesium absorption are not well-supported by absorption studies. Epsom salt baths feel pleasant but the magnesium absorbed transdermally is much less than oral intake at typical bath concentrations.

Cardiovascular outcome trials at scale. Magnesium-rich diets are associated with reduced cardiovascular events; whether magnesium supplementation produces similar event reduction in hard outcome trials at REDUCE-IT scale isn't established.

Optimal individual dose. RDA-based and general supplementation doses are population averages. Optimal individual dose depends on baseline status, kidney function, dietary intake, losses (sweat, alcohol, diuretics), and indication — and isn't systematically guided by current practice.

Where to buy magnesium

Magnesium is widely available with substantial variation in form. The key quality variable is matching the form to your goal (glycinate, citrate, oxide, threonate, malate all serve different use cases). Elemental magnesium content disclosure is essential — compound weight varies widely across forms.

Quality markers to look for

  • Form clearly disclosed — magnesium glycinate (bisglycinate), citrate, oxide, L-threonate, malate, etc. Generic "magnesium" without form is a yellow flag.
  • Elemental magnesium content disclosed — read past compound weight. 200 mg of magnesium glycinate compound contains less elemental magnesium than 200 mg of magnesium oxide compound.
  • Glycinate for general use — practical default. Capsules at 100–200 mg elemental magnesium per serving.
  • Citrate for general + mild laxative — cost-efficient general option.
  • Oxide for constipation only — cheap and effective for that indication; poor for general status correction.
  • L-Threonate (Magtein brand) only if specifically targeting cognition — accept thin evidence + premium price.
  • cGMP-certified manufacturing facility — minimum bar.
  • USP / NSF / ConsumerLab certified — third-party verification of label claims.
  • Reputable brands — Now Foods, Thorne, Pure Encapsulations, Doctor's Best (high-absorption glycinate is well-regarded), Klaire Labs, Jigsaw Health, BulkSupplements, Magtein-licensed brands for threonate.
  • Avoid "magnesium blend" products with multiple forms in proprietary undisclosed amounts.
  • Topical / transdermal magnesium products (oil, lotion, Epsom salt) — limited absorption evidence. Bath use is pleasant but not equivalent to oral supplementation.
Shop Magnesium on Amazon →

Amazon affiliate link — Prof. Peptide earns a small commission on qualifying purchases at no extra cost to you. We use commissions to fund research and editorial work.

Magnesium FAQ

Glycinate vs citrate vs oxide vs threonate — which magnesium form should I take?

Depends entirely on your goal — this is the central practical decision. Magnesium glycinate (bisglycinate) is gentle on GI, well-absorbed, and the default choice for general supplementation, sleep/anxiety contexts, and users who want magnesium without laxative effect. Magnesium citrate is well-absorbed and produces mild osmotic laxative effect — useful when constipation is part of the goal. Magnesium oxide has poor elemental bioavailability (~4%) but very strong osmotic effect — cheap and effective specifically for constipation, poor for general status correction. Magnesium L-threonate is marketed for cognitive applications based on Liu 2010 rodent data showing brain magnesium increases; human evidence is thin (Liu 2016 small trial) and the form is much more expensive than alternatives. Magnesium malate combines magnesium with malic acid — common in fatigue and fibromyalgia contexts. Practical default: glycinate for general use and sleep; citrate if constipation is also a goal; threonate only if specifically targeting cognitive applications and you accept the thin evidence + cost.

How much magnesium should I take?

200–400 mg elemental magnesium daily for general supplementation. The RDA is 320 mg for women and 420 mg for men (total intake including diet). Most users don't reach RDA from diet alone — surveys suggest 45–68% of Americans fall short. Supplemental 200–400 mg covers the gap without exceeding the supplemental tolerable upper limit (UL) of 350 mg/day from supplements. The UL specifically targets supplemental magnesium (where laxative effect kicks in) — it does NOT cap dietary magnesium intake, which has no documented toxicity ceiling in healthy users. Migraine prophylaxis protocol: 400–600 mg/day per AAN/AHS Level B recommendation (above UL but specifically for the migraine indication; coordinate with neurology). Higher doses are used in specific clinical contexts (eclampsia/pre-eclampsia uses IV magnesium sulfate under obstetric supervision). Practical guidance: 200–400 mg/day glycinate or citrate is the standard supplemental dose.

Will magnesium actually help me sleep?

Honestly, the evidence is thinner than the popular reputation suggests. The most-cited trial is Abbasi 2012 in 46 elderly insomniacs (small sample) — documented modest sleep quality improvement at 500 mg/day. Subsequent meta-analyses include limited RCTs with mixed results. The mechanism (GABA-A receptor potentiation, NMDA antagonism, calming effect) is biologically plausible. The honest framing: magnesium's sleep evidence is Emerging/Modest — not Strong despite the popular reputation. Effect is more pronounced in users who are deficient at baseline. If you're hoping for a sleep miracle, manage expectations — magnesium may modestly help, but it's not as robustly evidenced as the marketing suggests. Glycinate form is most commonly used for sleep applications. Take pre-bed if using for sleep.

Will magnesium help with muscle cramps?

For general/idiopathic muscle cramps in adults: NO, despite the popular reputation. Garrison 2020 Cochrane systematic review of 11 RCTs found magnesium supplementation did NOT significantly reduce cramp frequency, intensity, or duration in adults with idiopathic muscle cramps. This is the foundational evidence base — and it's negative. Where magnesium DOES help with cramps: (1) Pregnancy leg cramps — moderate evidence; (2) Exercise-associated cramps in users with documented deficiency — modest evidence. For typical adult muscle cramps without deficiency: magnesium is not the right tool. Cramp causality is more complex than just electrolyte depletion (see Schwellnus 2009 critique on the broader cramp-mechanism question). Honest framing: don't expect magnesium to solve generic muscle cramping.

Does magnesium help prevent migraines?

Yes — this is one of magnesium's better-evidenced applications. The American Academy of Neurology and American Headache Society give magnesium a Level B (probably effective) recommendation for migraine prophylaxis in their joint guideline. Standard dose: 400–600 mg/day elemental magnesium for 8–12 weeks to assess effect. Mechanism likely involves NMDA receptor modulation, vasodilation, and platelet aggregation effects. Migraine sufferers often have lower magnesium status than non-sufferers. The dose for migraine prophylaxis exceeds the general UL of 350 mg/day — coordinate with neurology if pursuing this protocol. Citrate, glycinate, or oxide forms have all been used in trials. Effect is preventive, not acute — magnesium during an active migraine doesn't abort it (though IV magnesium sulfate is used in some emergency department migraine protocols).

What's the deal with magnesium L-threonate and cognition?

Promising mechanism, thin human evidence, expensive form. Magnesium L-threonate was developed specifically to cross the blood-brain barrier and raise brain magnesium concentrations. Liu 2010 documented brain magnesium increases and learning/memory improvements in aged rats. Liu 2016 — the most-cited human trial — found modest cognitive improvements in older adults with cognitive impairment, but the trial was small (44 subjects) and industry-funded. Whether magnesium threonate produces meaningfully better cognitive outcomes than equivalent doses of other magnesium forms in healthy users isn't well-characterized. The form costs 5–10x more per mg of elemental magnesium than glycinate or citrate. Practical positioning: if you specifically target cognitive applications and accept the thin evidence + premium cost, threonate is the form designed for this. For general supplementation, the cost premium isn't justified. Threonate doesn't replace evidence-based cognitive interventions (sleep, exercise, social engagement, cardiovascular health).

Can magnesium lower my blood pressure?

Modestly — Moderate evidence. Zhang 2016 meta-analysis of 34 RCTs documented systolic BP reduction of approximately 2 mmHg and diastolic of approximately 1.78 mmHg with magnesium supplementation. Effect is larger in hypertensive populations and users with baseline magnesium insufficiency. Magnesium acts as a natural calcium channel blocker — regulating vascular smooth muscle tone. Effect size is modest compared to antihypertensive medications but additive to lifestyle interventions. Practical positioning: magnesium is reasonable as part of a comprehensive BP-management approach (DASH diet, exercise, weight management, potassium intake) rather than as a standalone BP intervention. Don't expect dramatic effects.

Is magnesium safe? Any major contraindications?

Generally very safe at standard supplemental doses in users with normal kidney function. The main practical considerations: (1) Tolerable upper limit from supplements is 350 mg/day — above this, laxative/diarrhea effect kicks in. Doesn't cap dietary intake. (2) Kidney disease — impaired magnesium clearance. Coordinate with nephrology before supplementing in chronic kidney disease. (3) Antibiotic interactions — magnesium chelates with quinolones, tetracyclines, and some others. Separate dosing by 2+ hours. (4) Bisphosphonates — magnesium reduces absorption. Separate by 2+ hours. (5) Heart block / bradycardia — high-dose magnesium can theoretically worsen. Generally not a concern at supplemental doses. (6) Magnesium toxicity (hypermagnesemia) is rare in users with normal kidneys but serious — causes muscle weakness, hypotension, respiratory depression. Almost exclusively occurs in kidney failure contexts or massive overdose.

References

  1. Schwalfenberg GK, Genuis SJ. The importance of magnesium in clinical healthcare. Scientifica. 2017;2017:4179326. https://pubmed.ncbi.nlm.nih.gov/29093983/
  2. Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68(2):324-333. https://pubmed.ncbi.nlm.nih.gov/27402922/
  3. Garrison SR, Korownyk CS, Kolber MR, et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. 2020;9(9):CD009402. https://pubmed.ncbi.nlm.nih.gov/32956536/
  4. Pringsheim T, Davenport WJ, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1-59. https://pubmed.ncbi.nlm.nih.gov/22529202/
  5. Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults: a randomized, double-blind, placebo-controlled trial. J Alzheimers Dis. 2016;49(4):971-990. https://pubmed.ncbi.nlm.nih.gov/26677804/
  6. Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169. https://pubmed.ncbi.nlm.nih.gov/23853635/

Published Studies

Plain-English summaries of the peer-reviewed studies behind the claims above. Click any title to read the source paper.

Scientifica · 2017Open Access
The Importance of Magnesium in Clinical Healthcare →

Schwalfenberg GK, Genuis SJ

A comprehensive review of magnesium biology and clinical applications. Documents magnesium's role as cofactor for 300+ enzymatic reactions; common deficiency prevalence (45–68% of US adults below RDA); clinical indications spanning cardiovascular, neurological, metabolic, and gastrointestinal applications. Foundational reference for the multi-indication evidence base.

Hypertension · 2016Open Access
Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials →

Zhang X, Li Y, Del Gobbo LC, et al.

A meta-analysis of 34 RCTs (2,028 participants) documenting magnesium supplementation reduced systolic BP by ~2 mmHg and diastolic BP by ~1.78 mmHg. Effect was larger in hypertensive populations and at doses of 300+ mg/day. The most-cited single source for magnesium's modest-but-real BP-lowering effect.

Cochrane Database of Systematic Reviews · 2020Open Access
Magnesium for Skeletal Muscle Cramps →

Garrison SR, Korownyk CS, Kolber MR, et al.

A Cochrane systematic review of 11 RCTs testing magnesium supplementation for skeletal muscle cramps in adults. Found NO statistically significant or clinically meaningful effect on cramp frequency, intensity, or duration in adults with idiopathic muscle cramps. The foundational evidence-based debunking of the popular "magnesium for cramps" claim in general adult populations. Pregnancy leg cramps and exercise-deficiency contexts may differ.

Neurology / Headache · 2012Open Access
Evidence-Based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults →

Pringsheim T, Davenport WJ, Mackie G, et al.

The American Academy of Neurology and American Headache Society joint guideline on migraine prophylaxis. Magnesium received a Level B recommendation (probably effective) at 400–600 mg/day. The foundational guideline reference for magnesium in migraine prophylaxis — one of the better-evidenced complementary medicine indications for this population.

Neuropharmacology · 2016Paywalled
Magnesium L-Threonate for the Treatment of Cognitive Impairment in Adults →

Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S

A small (n=44) 12-week trial of magnesium L-threonate in older adults with cognitive impairment. Documented modest improvements in cognitive function (memory, attention, processing speed). The most-cited human trial for magnesium L-threonate cognition claims; small sample, industry funding, and limited replication temper enthusiasm. The form's premium pricing isn't supported by strong human evidence vs other magnesium forms.

Journal of Research in Medical Sciences · 2012Open Access
The Effect of Magnesium Supplementation on Primary Insomnia in Elderly: A Double-Blind Placebo-Controlled Clinical Trial →

Abbasi B, Kimiagar M, Sadeghniiat K, et al.

The most-cited human trial for magnesium and sleep — a small (n=46) trial in elderly insomniacs documenting modest sleep quality improvements at 500 mg/day for 8 weeks. Small sample size and limited generalizability temper the evidence base. The popular reputation of magnesium for sleep significantly exceeds the underlying RCT base.

GlycinateCitrateMigraineCramps Cochrane NullThreonate ThinSleep Modest

Related Supplements

Vitamin D3ZincZMAMelatoninGlycineElectrolyte Powders

We may earn commissions from peptide vendor affiliate links.

Have a question about Magnesium? Send us an email →